Loading…

"Minho Technique" for Laparoscopic Radical Cystectomy with Intracorporeal Ileal Conduit

Radical cystectomy (RC) with ileal conduit (IC) remains a main treatment for muscle-invasive bladder cancer (MIBC). Laparoscopy in this multistage surgery is quite demanding, so laparoscopic RC (LRC) with intracorporeal IC (IIC) is a technically exceptional procedure. We aim to simplify it, demonstr...

Full description

Saved in:
Bibliographic Details
Published in:Urology research and practice 2024-05, Vol.50 (3), p.203-207
Main Authors: Cardoso, Andreia, Anacleto, Sara, Tinoco, Catarina Laranjo, Araújo, Ana Sofia, Capinha, Mariana, Pinto, Luís Borges, Coutinho, Aparício, Tavares, Catarina, Marques, Vera, Mota, Paulo, Mendes, Miguel, Oliveira, Carlos, Torres, João Pimentel, Carvalho-Dias, Emanuel
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Radical cystectomy (RC) with ileal conduit (IC) remains a main treatment for muscle-invasive bladder cancer (MIBC). Laparoscopy in this multistage surgery is quite demanding, so laparoscopic RC (LRC) with intracorporeal IC (IIC) is a technically exceptional procedure. We aim to simplify it, demonstrating our technique, step-by-step. We present a 4-port LRC with IIC and Bricker uretero-ileal anastomoses. The main difference is the immediate and complete posterior dissection, similar to the "Montsouris approach" for prostatectomy. A 70-year-old man with a 5 cm MIBC was subjected to our demonstrated procedure. The postoperative period was uneventful. Diet and ambulation: 2 days. Single-J stents removal: 4 weeks. MIBC N0 was confirmed. At 24 months, the patient is well, without complications (namely hydronephrosis or disease recurrence). LRC with IIC is demanding and requires laparoscopic expertise. However, if performed in a standardized fashion, as demonstrated through this case, and considering our center's experience, it seems feasible and safe with 4-port and standard material without a significant operative time increase, nor oncological or functional compromise.
ISSN:2980-1478
2980-1478
DOI:10.5152/tud.2024.23230